Adjunctive Corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia
Objectives: A mortality rate of non-human immunodeficiency virus–infected pneumocystis pneumonia (non-HIV PCP) is 30–60%. But the effectiveness of adjunctive corticosteroids with trimethoprim–sulfamethoxazole has been unclear, and we examined whether it lowered risk of mortality in non-HIV PCP. Meth...
Main Authors: | Norihiko Inoue, Kiyohide Fushimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-02-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971218349506 |
Similar Items
-
Adjunctive Corticosteroid Therapy Decreases Lung Permeability in Patients with AIDS-Related Pneumocystis carinii Pneumonia
by: Silvia Guillemi, et al.
Published: (1995-01-01) -
Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
by: Masato Tashiro, et al.
Published: (2017-12-01) -
Adjunctive corticosteroids for <it>Pneumocystis jiroveci </it>pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials
by: Furrer Hansjakob, et al.
Published: (2005-11-01) -
Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients
by: Maria L. Calero-Bernal, et al.
Published: (2016-01-01) -
A 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease.
by: Satoshi Shibata, et al.
Published: (2015-01-01)